title: Social phobia: an update on treatment.
abstract: Social phobia is a prevalent anxiety disorder that may be treated with pharmacotherapy, psychotherapy, or both. This article reviews the empirical evidence for these interventions and discusses new treatment developments. Active ingredients and mechanisms involved in the effectiveness of treatment are discussed. In addition, the elements of social phobia and its treatment that are similar to other anxiety and non-anxiety disorders are considered. Finally, it discusses future efforts to improve diagnosis and treatment for social phobia, including possible revisions to the diagnostic criteria that might be considered in the forthcoming fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, as well as routine care and obstacles for dissemination.
authors.affiliation: Adult Anxiety Clinic of Temple, Department of Psychology, Temple University, 1701 North 13th Street, Philadelphia, PA 19122-6085, USA.
authors.forename: Ellen C
authors.initials: EC
authors.lastname: Jørstad-Stein
authors.forename: Richard G
authors.initials: RG
authors.lastname: Heimberg
mesh_terms: D001569:Benzodiazepines / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000379:methods / Q000639:trends; D003523:Cycloserine / Q000627:therapeutic use; D017831:Diagnosis, Dual (Psychiatry); D039721:Diagnostic and Statistical Manual of Mental Disorders; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010698:Phobic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control / Q000628:therapy*; D011320:Primary Health Care / Q000379:methods; D011613:Psychotherapy / Q000379:methods* / Q000639:trends; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D001569:Benzodiazepines; D003523:Cycloserine; D008996:Monoamine Oxidase Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors